Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against <i>Mycobacterium kansasii</i>

The incidence of infections with nontuberculous mycobacteria (NTM) has been increasing worldwide. The emergence of multidrug-resistant NTM is a serious clinical concern, and a vaccine for NTM has not yet been developed. We previously developed a new recombinant Bacillus Calmette–Guérin (rBCG) vaccin...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shihoko Komine-Aizawa, Satoru Mizuno, Kazuhiro Matsuo, Takahiro Namiki, Satoshi Hayakawa, Mitsuo Honda
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-11-01
Colecção:	Vaccines
Assuntos:	<i>Mycobacterium kansasii</i> CD8<sup>+</sup> T Cells CD4<sup>+</sup> T Cells recombinant BCG
Acesso em linha:	https://www.mdpi.com/2076-393X/9/11/1260
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!